1,148
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

The impact of renal denervation procedure on use of antihypertensive drugs in the real-life setting

, , , &
Pages 245-253 | Received 28 Jun 2022, Accepted 15 Sep 2022, Published online: 22 Sep 2022

Figures & data

Table 1. Baseline characteristics of cohort members.

Figure 1. Number of drugs prescribed one year before and during the three years after renal denervation.

Figure 1. Number of drugs prescribed one year before and during the three years after renal denervation.

Table 2. Number of antihypertensive drug classes prescribed in the year before the index admission and during the 3 years after the index discharge.

Table 3. Antihypertensive drug classes prescribed during the year before the index admission and during the three years after the index discharge.

Table 4. Antihypertensive drug classes prescribed to control patients during the year before the index admission and during the three years after the index discharge of the corresponding patient who underwent the renal denervation.

Figure 2. Percentage of patients who experienced a hospitalisation for a cardiovascular event during the 3 years before and the three years after renal denervation.

Figure 2. Percentage of patients who experienced a hospitalisation for a cardiovascular event during the 3 years before and the three years after renal denervation.
Supplemental material

Supplemental Material

Download MS Word (30.2 KB)

Data availability statement

The data that support the findings of this study are available from Lombardy Region, but restrictions apply to the availability of these data, which were used under licence for the current study, and so are not publicly available. Data are however available from the Lombardy Region upon reasonable request.